These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9139108)

  • 1. Development of a common 3D pharmacophore for delta-opioid recognition from peptides and non-peptides using a novel computer program.
    Huang P; Kim S; Loew G
    J Comput Aided Mol Des; 1997 Jan; 11(1):21-8. PubMed ID: 9139108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.
    Shenderovich MD; Liao S; Qian X; Hruby VJ
    Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3D model of the delta opioid receptor and ligand-receptor complexes.
    Alkorta I; Loew GH
    Protein Eng; 1996 Jul; 9(7):573-83. PubMed ID: 8844829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of non-specific recognition of delta, mu, and kappa opioid receptors.
    Filizola M; Villar HO; Loew GH
    Bioorg Med Chem; 2001 Jan; 9(1):69-76. PubMed ID: 11197347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally readdressed CCK-B/delta-opioid peptide ligands.
    Nikiforovich GV; Kolodziej SA; Nock B; Bernad N; Martinez J; Marshall GR
    Biopolymers; 1995 Oct; 36(4):439-52. PubMed ID: 7578939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformationally sampled pharmacophore for peptidic delta opioid ligands.
    Bernard D; Coop A; MacKerell AD
    J Med Chem; 2005 Dec; 48(24):7773-80. PubMed ID: 16302816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2D conformationally sampled pharmacophore: a ligand-based pharmacophore to differentiate delta opioid agonists from antagonists.
    Bernard D; Coop A; MacKerell AD
    J Am Chem Soc; 2003 Mar; 125(10):3101-7. PubMed ID: 12617677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring deltorphin II binding to the third extracellular loop of the delta-opioid receptor.
    Fadhil I; Schmidt R; Walpole C; Carpenter KA
    J Biol Chem; 2004 May; 279(20):21069-77. PubMed ID: 14999000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition.
    Befort K; Tabbara L; Kling D; Maigret B; Kieffer BL
    J Biol Chem; 1996 Apr; 271(17):10161-8. PubMed ID: 8626577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
    Lomize AL; Pogozheva ID; Mosberg HI
    Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore.
    Bryant SD; Balboni G; Guerrini R; Salvadori S; Tomatis R; Lazarus LH
    Biol Chem; 1997 Feb; 378(2):107-14. PubMed ID: 9088539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking studies suggest ligand-specific delta-opioid receptor conformations.
    Micovic V; Ivanovic MD; Dosen-Micovic L
    J Mol Model; 2009 Mar; 15(3):267-80. PubMed ID: 19052783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
    Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds.
    Wilkes BC; Nguyen TM; Weltrowska G; Carpenter KA; Lemieux C; Chung NN; Schiller PW
    J Pept Res; 1998 May; 51(5):386-94. PubMed ID: 9606018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
    Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors.
    Filizola M; Laakkonen L; Loew GH
    Protein Eng; 1999 Nov; 12(11):927-42. PubMed ID: 10585498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity.
    Bernard D; Coop A; MacKerell AD
    J Med Chem; 2007 Apr; 50(8):1799-809. PubMed ID: 17367120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B; Meng F; Akil H
    Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational stability and three-dimensional model of the delta-opioid pharmacophore for the extended antiparallel dimer structure of Met-enkephalin in water.
    Wu YC; Hsieh JY; Lin HC; Hwang CC
    J Mol Model; 2007 Jan; 13(1):171-7. PubMed ID: 16972066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mu- and delta-opioid pharmacophore conformations of cyclic beta-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors.
    Brandt W; Stoldt M; Schinke H
    J Comput Aided Mol Des; 1996 Jun; 10(3):201-12. PubMed ID: 8808737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.